Delivery Order SPE2DB22D1106-SPE2DB25FFGM4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a ceiling value of $5,415.04 under a firm fixed-price contract type. The contract carries an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a contract ceiling value of $2,707.52. The delivery order is structured as a firm fixed price contract with a completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,153.20 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with a firm fixed price structure and an ultimate completion date of September 4, 2025. This contract is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The award was made competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,107.24 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 22, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $7,851.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a routine pharmaceutical procurement through DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,030.64 for Cervidil 10 mg vaginal inserts by the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGM4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a ceiling value of $8,461.00 and a firm fixed price structure. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order represents a discrete fulfillment within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which supports military and federal healthcare systems' medical supply chain requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated capability in fulfilling federal procurements for specialized pharmaceutical products and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The award of this obstetric medication aligns with the company's extensive portfolio of brand-name pharmaceuticals and medical commodities delivered through competitively awarded contracts with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/3/25 |